Compass Therapeutics, Inc. (CMPX) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CMPX Hot Sheet
Join SI Premium – FREE
Compass Therapeutics, Inc. (NASDAQ: CMPX) reported Q1 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Compass Therapeutics, Inc. (CMPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Starts Boyd Gaming (BYD) at Buy
- Autonomix Medical reports preclinical renal nerve sensing results
- Zebra Technologies debuts CV70 camera at Automate 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
